Cognitive pharmacy services at a pediatric nephrology and hypertension clinic

Renal Failure

Volumn 33, Issue 1, 2011, Pages 19-25

  So, Tsz Yin ^a   Bradley Layton, J ^b   Bozik, Kara ^c   Farrington, Elizabeth ^c   Gipson, Patrick E ^c   Gibson, Keisha ^c   Primack, William ^c   Conley Iii, William ^c   Gipson, Debbie S ^c   Ferris, Maria ^c  

^a MOSES H CONE MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

Chronic kidney disease; Cognitive pharmacy service; Electronic health record; Electronic medical profile; Electronic medical record; Hypertension; Kidney transplantation; Medication adherence; Medication counseling; Medication discrepancy; Pediatric

Indexed keywords

ARTICLE; CHILD; CLINICAL PRACTICE; COGNITIVE PHARMACY SERVICE; FEMALE; HOSPITAL DEPARTMENT; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT COUNSELING; PEDIATRIC HOSPITAL; PRIORITY JOURNAL;

AMBULATORY CARE FACILITIES; CHILD; FEMALE; HUMANS; HYPERTENSION; KIDNEY DISEASES; MALE; NEPHROLOGY; PHARMACEUTICAL SERVICES;

EID: 78651270539     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.536291     Document Type: Article

References (25)

1. Skaer TL. Dosing considerations in the pediatric patient. Clin Ther. 1991;13:526-544.
2. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47: 533-543.
3. Armstrong EP, Sclar DA. Disease management: State of the art and future directions. Clin Ther. 1999;21:593-609.
4. Bogden PE, Abbott RD, Williamson P, Onapa JK, Koonz LM. Comparing standard care with a physician and pharmacists team approach for uncontrolled hypertension. J Gen Intern Med. 1998;13:745-745.
5. Radley AS, Hall J, Farrow M, Carey PJ. Evaluation of anticoagulant control in a pharmacist operated anticoagulant clinic. J Clin Pathol. 1995;48:543-547.
6. Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother. 1996;30:238-243. (Pubitemid 126497295)
7. Bond CA, Salinger RJ. Fluphenazine outpatient clinic-pharmacists role. J Clin Psychiatry. 1979;40:501-503.
8. Monson R, Bond CA, Schuna A. Role of the clinical pharmacist in improving drug therapy. Clinical pharmacists in outpatient therapy. Arch Intern Med. 1981;141:1441-1444.
9. McKenney JM, Witherspoon JM. The impact of outpatient hospital pharmacists on patients receiving antihypertensive and anticoagulant therapy. Hop Pharm. 1985;20:406-415.
10. Dorevitch A, Aronzon R, Zilberman L. Medication maintenance of chronic schizophrenic outpatients by a psychiatric clinical pharmacist: 10-year follow-up study. J Clin Pharm Ther. 1993;18:183-186.
11. Manley HJ, Drayer DK, McClaran M, Bender W, Muther RS. Drug record discrepancies in an outpatient electronic medical record: Frequency, type, and potential impact on patient care at a hemodialysis center. Pharmacotherapy. 2003; 23:231-239.
12. Joy MS, DeHart RM, Gilmartin C, et al. Clinical pharmacists as multidisciplinary health care providers in the management of CKD: A joint opinion by the nephrology and ambulatory care practice and research networks of the American College of Clinical Pharmacy. Am J Kidney Dis. 2005; 45: 1105-1118. (Pubitemid 40806526)
13. Patel HR, Pruchnicki MC, Hall LE. Assessment for chronic kidney disease services in high-risk patients at community health clinics. Ann Pharmacother. 2005;39:22-27.
14. Hilbrands L, Hoitsma A, Koene R. Medication compliance after renal transplantation. Transplantation 1995; 60:914-920.
15. Sano PY, Masotti RR, dos Santos AA, Cordeiro JA. Evaluation of the understanding level of pediatric prescriptions. J Pediatr. (Rio J.) 2002;78:140-145.
16. Lau HS, Beuning KS, Postma-Lim E, Klein-Beernink L, Boer A, Porsius AJ. Non compliance in elderly people: Evaluation of risk factors by longitudinal data analysis. Pharm World Sci. 1996;18:63-68.
17. Matsui D. Current issues in pediatric medication adherence. Pediatr Drugs. 2007;9:283-288.
18. Ettenger RB, Rosenthal JT, Marik JL, et al. Improved cadaveric renal transplant outcome in children. Pediatr Nephrol. 1991;5:137-142.
19. Joy MS, Candiani C, Vaillancourt BA, Chin H, Hogan SL, Falk RJ. Reengineering clinical operations in a medical practice to optimize the management of anemia of chronic kidney disease. Pharmacotherapy. 2007;27:733-744.
20. Zillich AJ, Saseen JJ, Dehart RM, et al. Caring for patients with chronic kidney disease: A joint opinion of the ambulatory care and the nephrology practice and research networks of the American College of Clinical Pharmacy. Pharmacotherapy. 2005;25:123-143.
21. Belsante M, Burnett O, De Walt D, et al. Parental literacy and pediatric peritoneal dialysis outcomes. Abstract presented in JASN 2007;18:299A.
22. Davis TC, Wolf MS, Bass PF III, et al. Literacy and misunderstanding prescription drug labels. Ann Intern Med. 2006; 145:887-894.
23. Grimes T, Delaney T, Duggan C, Kelly JG, Graham IM. Survey of medication documentation at hospital discharge: Implication for patient safety and continuity of care. Ir J Med Sci. 2008;177:93-97.
24. Ong SW, Fernades OA, Cesta A, Bajcar JM. Drug-related problems on hospital admission: Relationship to medication information transfer. Ann Pharmacother. 2006;40:408-413.
25. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(Suppl. 1): S1-S266.